Nitrofurantoin Should NOT Be Used for Respiratory Tract Infections
Nitrofurantoin is absolutely contraindicated for treating respiratory tract infections—it is exclusively indicated for urinary tract infections and can actually cause severe, potentially irreversible pulmonary toxicity. 1
Why This Is Critical
Nitrofurantoin Causes Lung Damage, Not Lung Healing
The FDA drug label explicitly warns that nitrofurantoin causes chronic, subacute, or acute pulmonary hypersensitivity reactions with manifestations including:
- Cough, dyspnea, and chest pain
- Diffuse interstitial pneumonitis or fibrosis
- Permanent pulmonary function impairment even after stopping the drug
- Pulmonary infiltrates with consolidation or pleural effusion 1
These reactions can occur within the first week (acute) or after months of therapy (chronic), and pulmonary function may be permanently impaired if not recognized early 1. Recent case reports confirm patients developing progressive respiratory failure requiring hospitalization after nitrofurantoin use 2.
Nitrofurantoin Has No Activity in Respiratory Tissue
Nitrofurantoin achieves therapeutic concentrations only in urine, not in respiratory tissues. It is specifically designed and indicated for urinary tract infections where it concentrates in the urinary system 3, 4. Using it for respiratory infections would provide:
- Zero therapeutic benefit (no drug concentration at infection site)
- Maximum harm (pulmonary toxicity risk)
Appropriate Management of Respiratory Tract Infections
For acute uncomplicated bronchitis (the most common respiratory tract infection), antibiotics should not be used at all unless pneumonia is suspected 5. More than 90% of cases are viral and resolve without antibiotics 5.
Key clinical decision point: Pneumonia is unlikely in healthy adults under 70 years without ALL of the following:
- Heart rate >100 beats/min
- Respiratory rate >24 breaths/min
- Fever >38°C
- Abnormal chest exam findings (rales, egophony, tactile fremitus) 5
If antibiotics are truly needed for a bacterial respiratory infection, appropriate choices include beta-lactams, macrolides, or fluoroquinolones—never nitrofurantoin.
Common Pitfall to Avoid
Do not confuse nitrofurantoin's role in treating urinary tract infections (where it is first-line therapy 3, 4) with any role in respiratory tract infections (where it has none and causes harm). The similar terminology "tract infection" does not mean the drugs are interchangeable between organ systems.